Correlation between clinic and remote FEV1 and FeNO measurements; post hoc analysis of the INCONTRO study

S. Necander (Gothenburg, Sweden), M. Hashemi (Gothenburg, Sweden), Z. Taib (Gothenburg, Sweden), R. Palmér (Gothenburg, Sweden), K. Korsback (Gothenburg, Sweden), M. Aurell (Gothenburg, Sweden), S. Delaney (Gothenburg, Sweden), K. Pardali (Gothenburg, Sweden), P. Gustafson (Gothenburg, Sweden), D. Keeling (Gothenburg, Sweden), T. Sethi (Gothenburg, Sweden), I. Psallidas (Cambridge, United Kingdom)

Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Session: Exhaled biomarkers of asthma and the asthma burden
Session type: E-poster session
Number: 2173
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Necander (Gothenburg, Sweden), M. Hashemi (Gothenburg, Sweden), Z. Taib (Gothenburg, Sweden), R. Palmér (Gothenburg, Sweden), K. Korsback (Gothenburg, Sweden), M. Aurell (Gothenburg, Sweden), S. Delaney (Gothenburg, Sweden), K. Pardali (Gothenburg, Sweden), P. Gustafson (Gothenburg, Sweden), D. Keeling (Gothenburg, Sweden), T. Sethi (Gothenburg, Sweden), I. Psallidas (Cambridge, United Kingdom). Correlation between clinic and remote FEV1 and FeNO measurements; post hoc analysis of the INCONTRO study. 2173

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study
Source: ERJ Open Res, 5 (1) 00243-2018; 10.1183/23120541.00243-2018
Year: 2019



Improvements in lung function with umeclidinium/vilanterol analysed by reversibility at screening: a post hoc analysis of the EMAX trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Characterising patients with COPD by baseline short-acting ß2-agonist (SABA) use: a post hoc analysis of the EMAX trial
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020


Correlation between home and clinic spirometry in subjects with IPF: results from the INMARK trial
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


A comparison of FEV1 measurements performed by children in the school and in the laboratory
Source: Eur Respir J 2007; 30: Suppl. 51, 377s
Year: 2007

Nintedanib in IPF: post hoc analysis of the Italian FIBRONET observational study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
Source: International Congress 2017 – COPD management
Year: 2017


Correlation of six minute walk test with spirometry in COPD patients
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021


A retrospective analysis of methacholine challenge test measurements
Source: Eur Respir J 2003; 22: Suppl. 45, 277s
Year: 2003

Reproducibility data of breath analysis through a gas sensors array and comparison to spirometry in COPD patients
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011

Impact of grouping patients by 2017 GOLD strategy assessment criteria: a post hoc analysis of the TONADO and OTEMTO trials
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017


A new diagnostic test for occupational asthma utilising the difference in hourly peak expiratory flow between work and rest days
Source: Annual Congress 2007 - Occupational asthma
Year: 2007


Comparison of the asthma control test and % predicted FEV1 in relation to correlation with physicians assessment of asthma control and treatment decisions
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011


Do changes in spirometric indices and FeNO predict asthma outcomes in children? An individual patient data analysis using results from seven FeNO trials
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018



Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial
Source: Eur Respir J, 52 (2) 1800555; 10.1183/13993003.00555-2018
Year: 2018



The annual decline in FEV1 is steeper if it is estimated from baseline data using cross-sectional analysis than obtained by longitudinal analysis
Source: Annual Congress 2008 - Air pollution effects on lung and heart
Year: 2008


Improvement of quality of spirometric measurements after analysis of errors detected by spirometric software
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013

Mometasone/ indacaterol/ glycopyrronium demonstrates similar efficacy in men and women: post hoc analysis of IRIDIUM study
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021


The diagnosis of occupational asthma from timepoint differences in serial PEF measurements
Source: Annual Congress 2009 - Occupational asthma in the clinic
Year: 2009


Asthma control test (ACTÔ) problem and the complementary effect by peak flow rate (PEFR) measurement at outpatient department
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008